M Bayes, X Rabasseda, JR Prous - Methods and findings in experimental and clinical …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP
Mohana Priya, M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G.
Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
S Rösch, R Ramer, K Brune, B Hinz - Biochemical and Biophysical Research …, 2005 - Elsevier Prostaglandins (PGs) have been implicated in lowering intraocular pressure
(IOP). A possible role of cyclooxygenase-2 (COX-2) in this process was
emphasized by findings showing impaired COX-2 expression in the ... Cited by 16 - Related articles - All 5 versions
N Ishida, N Odani-Kawabata, A Shimazaki, H … - Cardiovascular drug reviews, 2006 - interscience.wiley.com Elevated intraocular pressure (IOP) is one of the most important risk factors
for the development of glaucoma, which is a progressive optic neuropathy.
Lowering IOP is currently the only therapeutic approach to the therapy of ... Cited by 11 - Related articles - BL Direct - All 4 versions
- ►iovs.org T Ota, M Aihara, T Saeki, S Narumiya, M Araie - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Animals were bred and acclimatized in a 12-hour light-dark cycle. The
diurnal IOP variation was measured by a microneedle method in EP1, EP2, and EP3
receptor-deficient mice (EP1KO, EP2KO and EP3KO) and in their wild-type ... Cited by 10 - Related articles - BL Direct - All 3 versions
T Ota, M Aihara, T Saeki, S Narumiya, M Araie - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: C57BL/6J, and EP1, EP2, EP3 and postaglandin F (FP) receptor-deficient
wild-type (WT), EP1KO, EP2KO, EP3KO and FPKO, respectively mice were bred and
acclimatised under a 12-h (6:00–18:00) light–dark cycle. To evaluate ... Cited by 8 - Related articles - BL Direct - All 4 versions
- ►nih.gov RRA Bourne - British Journal of Ophthalmology, 2006 - bjo.bmj.com The report by Quigley and Broman in this issue of the BJO (p 262) is an
important and timely addition to our knowledge in this area. They have estimated
the worldwide prevalence of glaucoma for 2010 and 2020. Since Quigley's ... Cited by 4 - Related articles - BL Direct - All 8 versions
- ►nih.gov T Chiba, K Kashiwagi, N Chiba, S Tsukahara - British Journal of Ophthalmology, 2006 - bjo.bmj.com Methods: Examination was conducted on 16 eyes of 16 glaucoma patients who had
been given only latanoprost for at least 6 weeks. The NSAID ophthalmic solution,
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate, was ... Cited by 4 - Related articles - BL Direct - All 7 versions
R vandervalk, CB Webers, F Hendrikse, S … - Acta Ophthalmologica, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - BL Direct - All 2 versions
- ►nih.gov A Alm - British Journal of Ophthalmology, 2006 - bjo.bmj.com When the prostaglandin analogues were introduced a frequently asked question was
would the use of an oral non-steroid anti-inflammatory drug (NSAID) blunt the
effect of prostaglandin analogues on intraocular pressure (IOP)? ... Cited by 1 - Related articles - BL Direct - All 6 versions
C Costagliola, F Parmeggiani, A Caccavale, A … - American journal of ophthalmology, 2006 - Elsevier To verify the short-term influence of an orally administered nonsteroidal
anti-inflammatory drug on the intraocular pressure (IOP) of primary open-angle
glaucoma patients in therapy with a topical prostaglandin analog. Cited by 1 - Related articles - All 13 versions
